Ann: Imagion Biosystems September 2021 Investor Newsletter, page-21

What part of the update was brilliant and what part indicated he had been working hard? He just keeps rehashing old stuff because nothing is happening. Literally the second paragraph:

"Since our last Investor Newsletter in March, the most important accomplishment for our company has been our progression to “clinical stage” with the start of our MagSense® HER2 breast cancer Phase I study."

Yet the study had already started in March?

"With the Phase 1 study for our MagSenseTM HER2 breast cancer imaging agent underway, the task of recruiting patients is now largely in the hands of our clinical sites"